•
Mar 31, 2018

Outlook Therapeutics Q2 2018 Earnings Report

Total Revenue
$772K
Previous year: $303K
+154.6%
EPS
-$20.8
Previous year: -$23.2
-10.3%
Gross Profit
$0
0
Cash and Equivalents
$5.94M
Previous year: $81K
+7224.1%
Free Cash Flow
-$7.71M
Total Assets
$27.8M
Previous year: $17.5M
+59.1%

Outlook Therapeutics

Outlook Therapeutics